Stephen John Carter Insider Profile
4 Followers
Stephen John Carter, Chief Executive Officer at Arovella Therapeutics Limited, holds 18.09M shares in Arovella Therapeutics Limited (Ticker: AU:ALA). Most recently, Stephen John Carter Bought 4,522,222 shares of Arovella Therapeutics Limited on Jun 28, 2019 for an estimated value of AU$18.09K.
Stephen John Carter's Trading History
| ALAArovella Therapeutics Limited | Jun 28, 2019 | Chief Executive Officer | Informative Buy | 18.09K | AU$886.36K | ||||||||||||||||||||||||||||||||||||
AU:ALA Insider Shares: 18.09M (147.77%)
| |||||||||||||||||||||||||||||||||||||||||
You May Also Like
Stephen John Carter insider profile FAQ
What is the percentage of profitable transactions made by Stephen John Carter?
The percentage of profitable transactions made by Stephen John Carter is 0%.
What is the average return per transaction made by Stephen John Carter?
The average return per transaction made by Stephen John Carter is -40.90%.
What stocks does Stephen John Carter hold?
Stephen John Carter holds: AU:ALA stocks.
What was Stephen John Carter’s latest transaction?
Stephen John Carter’s latest transaction was an Informative Buy of AU$18.09K.
What was Stephen John Carter's most profitable transaction?
Stephen John Carter’s most profitable transaction was an Informative Buy of AU:ALA stock on November 17, 2017. The return on the trade was -39.40%.
What is Stephen John Carter's role in Arovella Therapeutics Limited?
Stephen John Carter's role in Arovella Therapeutics Limited is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
